GLP-3 RT 60mg Peptides

Built for rigorous benchwork, this lyophilized vial is developed to support consistent, reproducible peptide research from first run to final result.

Peptide Scientific Labs GLP-3 RT is supplied as a lyophilized vial designed for laboratory workflows that require careful handling and dependable quality. This single-vial format contains a total of 60mg of GLP-3 RT, enabling controlled preparation and study within established research protocols.

  • Each vial contains 60mg of GLP-3 RT, a receptor-targeted GLP-class analogue evaluated in research settings for receptor-binding kinetics, signaling pathway interrogation, stability characterization, and method development.

As a non-edible research material, the lyophilized format offers practical handling in controlled environments. Researchers value the clear, consistent reconstitution profile with suitable laboratory diluents, supporting in vitro assay design, reference standardization, and exploratory studies. The single-vial configuration helps streamline aliquoting strategies and minimizes unnecessary exposure during preparation.

Every step from sourcing to final packaging reflects an emphasis on integrity and traceability. Peptide Scientific Labs prioritizes controlled manufacturing practices, careful environmental monitoring, and meticulous lot segregation to help protect sample identity. Batches are tested using analytical methods such as HPLC and LC-MS to verify identity and assess purity, with results documented for transparency. Packaging is designed for secure transport and reliable presentation at the bench, supporting chain-of-custody confidence across internal teams and partner laboratories.

Quality you can document: Each lot is supported by a Certificate of Analysis to confirm specifications. Materials are handled under disciplined conditions to reduce variability and help safeguard consistency across studies. As a USA-based research brand, Peptide Scientific Labs aligns its peptide program around clear standards, careful documentation, and professional presentation so your team can focus on the science at hand.

Research-use only: This product is intended solely for laboratory research. Not for human consumption, medical, or veterinary use. Handle using appropriate laboratory precautions and follow institutional guidelines for storage, reconstitution, and disposal.

Total Strength
60mg
Strength Per vial
60mg/vial
Total Units
1 vial
Weight
0.70oz

  • Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
  • Shipping is free on orders of $99+ (except Hawaii and Alaska).
  • All orders ship in discreet packaging via USPS Ground Advantage mail.

Delivery restrictions vary by state.

Customer Reviews

There are no reviews yet. Be the first to write a review!

Frequently Asked Questions

What is GLP-3 RT?

GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.

What is GLP-3 RT typically studied for?

Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.

What are GLP peptides?

GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.

A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.

How do GLP analogs differ from native GLP hormones?

Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.

This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.

What is the difference between GLP-1, GLP-2, and GLP-3 in research?

GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.

GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.

Recently Viewed